VOYA Investment Management
CTMX icon

VOYA Investment Management’s CytomX Therapeutics CTMX Stock Holding History

VOYA Investment Management’s Portfolio CTMX Stock Details CTMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-25,786
Closed -$69K – 2797
2022
Q1 		$69K Sell
25,786
-545
-2% -$2.09K ﹤0.01% 2560
2021
Q4 		$114K Sell
26,331
-158
-0.6% -$926 ﹤0.01% 2650
2021
Q3 		$134K Buy
26,489
+188
+0.7% +$1.01K ﹤0.01% 2676
2021
Q2 		$166K Buy
26,301
+2,579
+11% +$20.1K ﹤0.01% 2657
2021
Q1 		$183K Buy
23,722
+4,118
+21% +$32.6K ﹤0.01% 2566
2020
Q4 		$128K Buy
19,604
+4,007
+26% +$28.6K ﹤0.01% 2515
2020
Q3 		$104K Hold
15,597
– – ﹤0.01% 2333
2020
Q2 		$130K Sell
15,597
-7,602
-33% -$70.6K ﹤0.01% 2286
2020
Q1 		$178K Hold
23,199
– – ﹤0.01% 2168
2019
Q4 		$193K Buy
23,199
+3,852
+20% +$26K ﹤0.01% 2384
2019
Q3 		$143K Hold
19,347
– – ﹤0.01% 2320
2019
Q2 		$217K Buy
19,347
+1,306
+7% +$13.7K ﹤0.01% 2258
2019
Q1 		$194K Hold
18,041
– – ﹤0.01% 2278
2018
Q4 		$272K Buy
18,041
+1,862
+12% +$27.6K ﹤0.01% 2084
2018
Q3 		$299K Buy
16,179
+1,223
+8% +$27.9K ﹤0.01% 2149
2018
Q2 		$342K Buy
14,956
+1,868
+14% +$47.7K ﹤0.01% 2069
2018
Q1 		$372K Hold
13,088
– – ﹤0.01% 1982
2017
Q4 		$276K Hold
13,088
– – ﹤0.01% 2183
2017
Q3 		$238K Hold
13,088
– – ﹤0.01% 2299
2017
Q2 		$203K Buy
+13,088
New +$197K ﹤0.01% 2403

Other funds holding CTMX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

VOYA Investment Management's CTMX Position: Q2 2022 in Review

VOYA Investment Management sold out of CytomX Therapeutics (CTMX) in Q2 2022, closing a stake of 25,786 shares — an estimated $69K sold.

VOYA Investment Management first reported a position in CTMX in Q2 2017 and held it in 20 quarters. The position peaked at $372K in Q1 2018. 98 funds tracked by Wall St. Rank hold CTMX as of Q2 2022.

  • VOYA Investment Management reported no remaining CytomX Therapeutics position as of Q2 2022 after selling out during the quarter.
  • VOYA Investment Management sold 25,786 CytomX Therapeutics shares in Q2 2022, an estimated $69K.
  • VOYA Investment Management first reported a position in CytomX Therapeutics in Q2 2017 and held it in 20 quarters.
  • VOYA Investment Management's CytomX Therapeutics position peaked at $372K in Q1 2018.
  • 98 funds tracked by Wall St. Rank held CytomX Therapeutics as of Q2 2022.

Based on VOYA Investment Management's 13F filing for Q2 2022, filed 15 Aug 2022.